Search clinical trials for: Antineoplastic and Immunomodulating Agents

Total 187210 results

Groupe Hospitalier Pitie-Salpetriere

Completed

Evaluation of Reporting of Cardio-vascular Adverse Events With Antineoplastic and Immunomodulating Agents (EROCA) (EROCA)

Cancer | Cardiac Disease

France
University Hospital, Caen

Recruiting

Evaluation of Reporting of AdVerse Events Associated With AnTicAncer theRapy (AVATAR) (AVATAR)

Cancer

France
Bristol-Myers Squibb

Recruiting

A Study to Evaluate Satisfaction With Care in Patients With Cancer Receiving Immunotherapy Treatment at Home

Cancer | Solid Tumors

France
University of Oklahoma

Active, not recruiting

Analyzing Clinical Outcomes and Genomic Data of American Indian Patient Population (SCC-ClinO+Ge)

Melanoma | Renal Cell Carcinoma | Nonsmall Cell Lung Cancer | Metastatic Solid Tumor | Gastrointestinal Cancer | Immune Checkpoint Inhibitors | Squamous Cell Carcinoma

United States
Joachim Aerts, MD PhD

Recruiting

The Effects of an Nutritional Intervention on PD-1 ICI in NSCLC (NutriCim)

Non-small Cell Lung Cancer

Netherlands
Wuhan Union Hospital, China

Suspended

Radiotherapy With Neoadjuvant Chemotherapy and Immunotherapy in Rectal Cancer

Rectal Cancer | Radiotherapy | Immunotherapy | Organ Preservation

China
Zhiyong Huang
Wuhan University; Hubei Cancer Hospital; Wuhan Union Hospital, China; Renmin Hospital... and other collaborators

Recruiting

Impact of Splenectomy on the Efficacy of Targeted Therapy and Immunotherapy in Unresectable HCC Patients With Cirrhotic Portal Hypertension

Unresectable Hepatocellular Carcinoma

China
Qianfoshan Hospital

Recruiting

A Retrospective Study on the Treatment of Intermediate and Advanced Liver Cancer.

Carcinoma, Hepatocellular

China
Shanghai Chest Hospital

Recruiting

Radiotherapy Combined With Immunochemotherapy in Metastatic Esophageal Squamous Cell Carcinoma

Esophageal Cancer | Esophageal Squamous Cell Carcinoma | Metastatic Esophageal Squamous Cell Carcinoma

China
University of Maryland, Baltimore
AstraZeneca; West Penn Allegheny Health System; University of Arizona

Active, not recruiting

Neoadjuvant Durvalumab and Tremelimumab Plus Radiation for High Risk Soft-Tissue Sarcoma (NEXIS)

Soft Tissue Sarcoma

United States
Cancer Institute and Hospital, Chinese Academy...

Recruiting

Induction Chemoimmunotherapy Combined With Chemoradiotherapy in Esophageal Cancer

Esophageal Cancer | Surgery | Immunotherapy | Chemoradiotherapy | Induction Therapy

China
Cancer Institute and Hospital, Chinese Academy...

Recruiting

The Predictive Biomarkers in Patients With Locally Advanced Non-small Cell Lung Cancer

Locally Advanced Non-small Cell Lung Cancer

China
Tianjin Medical University Cancer Institute and...
The First Affiliated Hospital with Nanjing Medical University; Shanxi Province... and other collaborators

Completed

Real-world Experience of ICIs Plus Chemotherapy With or Without Radiotherapy for Advanced ESCC. (REICRAE)

Metastatic Esophageal Squamous Cell Carcinoma

China
Peking University First Hospital

Recruiting

Adjuvant Radiotherapy and Combined Adjuvant Treatment Strategy for UTUC

Urothelial Carcinoma

China
Changzhou No.2 People's Hospital

Not yet recruiting

FMT+Immunotherapy+Chemotherapy as First-line Treatment for Driver-gene Negative Advanced NSCLC

Non-small Cell Lung Cancer
Changzhou No.2 People's Hospital

Not yet recruiting

FMT+SOX+Sintilimab as First-line Treatment for Advanced Gastric Cancer

Gastric Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Recruiting

Downstaging Protocol Containing Immunotherapy for HCC Beyond the Milan Criteria Before Liver Transplantation (HLPDTLT)

Liver Transplantation | Hepatocellular Carcinoma

China
Sun Yat-sen University

Completed

Split-course Hypofractionated Radiotherapy With Concurrent Chemotherapy in Locally Advanced Non-small Cell Lung Cancer

Non-small Cell Lung Cancer

China
Cancer Institute and Hospital, Chinese Academy...

Recruiting

Real-world Clinical Outcomes of NSCLC Patients Receiving Neoadjuvant Immunotherapy (NeoIM-Lung)

NSCLC

China
Sun Yat-sen University

Completed

Fraction Dose Escalation of Hypo-fractionated Radiotherapy in LANSCLC

Locally Advanced Lung Carcinoma

China
Sun Yat-sen University

Not yet recruiting

Investigation of Multi-omics Technique to Predict the Efficacy of Chemoradiotherapy Combined With Immunotherapy for r/m NPC

Nasopharyngeal Carcinoma | Recurrent and Metastatic Nasopharyngeal Carcinoma | Multi-omics Technique | Efficacy of Chemoradiotherapy and Immunotherapy

China
University of Manitoba
AstraZeneca; Manitoba Medical Service Foundation; CancerCare Manitoba

Recruiting

Organ-Preserving Endoscopic Resection & Adjuvant RADIO-immuno-chemotherapy for Esophageal Cancer (OPERARADIO)

Esophageal Cancer

Canada
Hubei Cancer Hospital

Recruiting

Single-drug Chemotherapy Plus Immunotherapy in Metastatic Non-small Cell Lung Cancer Elderly Patients

Metastatic Lung Cancer | Elderly Patients

China
TheraOp
AstraZeneca

Active, not recruiting

PACCELIO - FDG-PET Based Small Volume Accelerated Immuno Chemoradiotherapy in Locally Advanced NSCLC (PACCELIO)

Stage III Non-small Cell Lung Cancer | Locally Advanced | Unresectable

Switzerland
Medical University of Graz

Recruiting

Nasal Mucus Proteome and Immunotherapy

Allergic Rhinoconjunctivitis

Austria
Sun Yat-sen University

Recruiting

Fraction Dose Escalation of Split-course Hypofractionated Concurrent Chemoradiotherapy Following Induction Chemo-immunotherapy in Unresectable Locally Advanced Esophageal Squamous Carcinoma: a Phase I Study.

Esophageal Squamous Cell Carcinoma

China
Capital Medical University

Completed

Concurrent Chemoradiation With or Without DC-CIK Immunotherapy in Treating Locally Advanced Esophageal Cancer

Esophageal Carcinoma

China
Shanghai Chest Hospital

Recruiting

Association of Psychological Distress in Patients With Lung Cancer (Life-Score)

Lung Neoplasms | Psychological Distress | IMMUNOTHERAPY | Lifestyle, Healthy | Targeted Molecular Therapy | Prognosis Factors

China
Xiangya Hospital of Central South University

Recruiting

Efficacy and Safety of NSCLC Patients With/Without Adjuvant Immunotherapy Who Have Achieved pCR After Neoadjuvant Immunotherapy

Resectable/Potentially Resectable NSCLC

China
Central South University

Completed

Evaluation of Reporting of Antibody-Drug Conjugate Associated Sepsis-related Toxicities

Agranulocytosis | Opportunistic Infections | Sepsis (SMQ)

China
Cliniques universitaires Saint-Luc- Université...

Active, not recruiting

Prospective Collection of Tumor Biopsy and Plasma Samples From Cancer Patients Treated With Molecular Targeted Therapies or Immunotherapy (Plasma-Target)

Cancer

Belgium
General Administration of Military Health, Tunisia

Recruiting

e-ITAG Allergen Immunotherapy in the Management of Allergic Asthma (EITAG)

Study the Efficacy of ITA in Patients With Allergic Asthma or Allergic Rhinitis or Allergic Rhinitis Compared With Conventional Treatment

Tunisia
Institut de cancérologie Strasbourg Europe
Institut National de la Santé Et de la Recherche Médicale, France; Centre National...

Recruiting

Identification of Predictive Factors for the Response to Anti-Programmed Cell Death Protein 1 (PD1) Immunotherapy in Head and Neck Squamous Cell Carcinoma (IPRICE)

Head and Neck Cancer

France
Seoul St. Mary's Hospital

Active, not recruiting

Compare Clinical Outcomes Between Advanced Immunotherapy and Classical Immunochemotherapy in RRMM (CAREMM-2305)

Myeloma Multiple

Korea, Republic of
Objectif Recherche Vaccins SIDA
Merck Sharp & Dohme LLC; Pfizer; Cytheris SA

Completed

Therapeutic Intensification Plus Immunomodulation in HIV-infected Patients (ERAMUNE-01)

HIV-1 Infection

United Kingdom, France, Italy, Spain
Indiana University

Recruiting

Organoid Model Predictive of Response to Immunotherapies

Breast Cancer

United States
Seoul St. Mary's Hospital

Active, not recruiting

CAREMM-2306: Advanced Immunotherapy vs. Classical Immunotherapy

Lymphoma

Korea, Republic of
Prince of Songkla University

Recruiting

Differences in Rate of Decline in CT-defined Skeletal Muscle Mass and Physical Performance in Patients With Advanced Non-small Cell Lung Cancer Receiving Chemotherapy and Targeted Therapy/Immunotherapy, Before and After Treatment.

Sarcopenia | Advanced Lung Cancer

Thailand
Peking University Cancer Hospital & Institute
Beijing Nanjiao Cancer Hospital

Recruiting

Total Neoadjuvant Treatment ±Immunotherapy for High Risk Locally Advanced Rectal Cancer (TNTi)

Rectal Cancer

China
Cancer Institute and Hospital, Chinese Academy...

Recruiting

Neoadjuvant Treatment Real-world Clinical Outcomes in NSCLC (NeoR-World)

Non-Small Cell Lung Cancer

China
Boehringer Ingelheim

Completed

Chart Review Study to Describe the Clinical Profile of Idiopathic Pulmonary Fibrosis (IPF) Patients Treated With Nintedanib (OFEV®) in Real-world Practice in Spain

Idiopathic Pulmonary Fibrosis

Spain
H. Lee Moffitt Cancer Center and Research Institute
United States Department of Defense

Active, not recruiting

HER2 Directed Dendritic Cell Vaccine During Neoadjuvant Therapy of HER2+Breast Cancer

Breast Cancer | Breast Cancer, Male | HER2-positive Breast Cancer | Invasive Breast Cancer | Stage II Breast Cancer | Breast Cancer Female | HER2 Positive Breast Carcinoma | Stage III Breast Cancer

United States
Medical University of Warsaw

Not yet recruiting

Efficacy of Cashew Nut Protein Immunotherapy

Food Allergy

Poland
Sun Yat-sen University
Henan Cancer Hospital; Jiangmen Central Hospital

Completed

Relation Between Tumor-draining Lymph Nodes Metastasis Pattern and Non-small Cell Lung Cancer Neoadjuvant Immunotherapy Effectiveness

Lung Cancer

China
University Hospital, Geneva

Terminated

Pilot Study on Immunotherapy for the Treatment of Persistant Peanut Allergy

Peanut Allergy | Food Allergy

Switzerland
The Fourth Affiliated Hospital of Zhejiang University...
Second Affiliated Hospital, School of Medicine, Zhejiang University

Active, not recruiting

Combined Statin and PD-1/PD-L1 Inhibitors in Treating Non-small Cell Lung Cancer

Lung Cancer

China
Hunan Province Tumor Hospital

Recruiting

Immune Treatment of Brain Metastasis of Lung Cancer Combined With Large-segmentation Precision Radiotherapy

Non Small Cell Lung Cancer

China
Bo Lu
National Cancer Institute (NCI)

Recruiting

Cardiopulmonary Monitoring in Lung Cancer Patients Receiving Combined Thoracic Radiotherapy and Immunotherapy

Lung Cancer

United States
Capital Medical University

Completed

Gene Expression Profiling of Malignant Tumor Predict the Therapeutic Response of DC-CIK Immunotherapy

Malignant Tumor

China
Capital Medical University

Completed

Study of Gene Expression Profiling and Immunological Mechanism Affects the Response of Immunotherapy

Malignant Tumor

China

Search clinical trials for: Antineoplastic and Immunomodulating Agents

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ecuador

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations